Browsing by Subject "A61K 2039/522"
Now showing items 1-10 of 10
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-12-10)Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-06-26)Provided herein are Salmonella enteritidis 13A strains and compositions comprising these strains. Also provided are methods of enhancing an immune response against Influenza A and methods of reducing morbidity associated ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2020-10-06)Vaccine vectors and methods of using the vaccine vectors to enhance the immune response to an Apicomplexan parasite and reduce the morbidity or mortality associated with subsequent infection are provided herein. The vaccine ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-09-08)Vaccines comprising fliC and CD 154 polypeptides and Salmonella enteritidis vaccine vectors comprising fliC polypeptides are provided. Also provided arc methods of enhancing an immune response against flagellated bacteria ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2016-02-02)Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2021-03-09)Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-05)Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-03-05)Methods and compositions for the treatment of Brucella induced diseases and disorders are disclosed herein. In preferred embodiments, the invention relates to vaccines. In additional embodiments, the invention relates to ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2015-02-17)Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-03-13)Provided herein are vaccine vectors including an antigenic polypeptide and an HMGB1 polypeptide present on the surface of the vaccine vector. Compositions comprising the vaccine vectors are also provided and include a ...